2023
DOI: 10.1016/j.ajp.2022.103358
|View full text |Cite
|
Sign up to set email alerts
|

Atypical development in white matter microstructures in ADHD: A longitudinal diffusion imaging study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 34 publications
0
1
0
Order By: Relevance
“…Our data indicate that the maturational profile of sensorimotor microstructure (more specifically, the bilateral CST) from late childhood into adolescence, may offer insight into the presence of motor difficulties in a sub‐set of adolescents with ADHD. Though recent work has mapped the development of microstructure of the CST in those with ADHD (Chiang et al, 2023 ), it did not evaluate its impact on functional motor outcomes. Thus, the degree to which microstructure of the CST, and its maturational profile, might distinguish those with ADHD who present with motor problems from those who do not was unclear.…”
Section: Discussionmentioning
confidence: 99%
“…Our data indicate that the maturational profile of sensorimotor microstructure (more specifically, the bilateral CST) from late childhood into adolescence, may offer insight into the presence of motor difficulties in a sub‐set of adolescents with ADHD. Though recent work has mapped the development of microstructure of the CST in those with ADHD (Chiang et al, 2023 ), it did not evaluate its impact on functional motor outcomes. Thus, the degree to which microstructure of the CST, and its maturational profile, might distinguish those with ADHD who present with motor problems from those who do not was unclear.…”
Section: Discussionmentioning
confidence: 99%
“…With the improvement in DSI data acquisition, more attention has recently been paid to its application in clinical diseases, including attention-deficit/hyperactivity disorder (ADHD) [2,64,65], schizophrenia [66][67][68], stroke [69][70][71][72], Parkinson's disease [73,74], hypertension [75], autism [76], epilepsy [77], and gliomas [78] (see Table 2).…”
Section: Clinical Applicationsmentioning
confidence: 99%